Symbolbild · KI-generiert
DiagnosTear Technologies Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
DiagnosTear is focused on the diagnosis of front-of-the-eye diseases at the point of care, by analyzing the composition of the tear fluid using its proprietary non invasive TeaRx™ technology and currently has two products for diagnosis of Dry Eye Disease and Red Eye causes.
Company description as published by the issuer via Canadian Securities Exchange.
Comparable companies
Companies in the Artificial Intelligence & Software sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| DiagnosTear Technologies Inc. | DTR | CSE | 13 Mio. USD |
| Miivo AI Inc | MIVO | TSXV | 13 Mio. USD |
| Clip Money Inc. | CLIP | TSXV | 13 Mio. USD |
| Plaid Technologies Inc. | STIF | CSE | 13 Mio. USD |
| OverActive Media Corp. | OAM | TSXV | 13 Mio. USD |
| IC Group Holdings Inc. | ICGH | TSXV | 13 Mio. USD |
| Prospect Prediction Markets Inc. | MKT | TSXV | 14 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.